Tech Company Financing Transactions
Recursion Pharmaceuticals Funding Round
Private investors invested in a $4.1 million funding round for Recursion Pharmaceuticals. This VC investment round was announced on 9/15/2016.
Transaction Overview
Company Name
Announced On
9/15/2016
Transaction Type
Venture Equity
Amount
$4,066,996
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 31 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
41S Rio Grande St.
Salt Lake City, UT 84101
USA
Salt Lake City, UT 84101
USA
Phone
Website
Email Address
Overview
At Recursion, we are Making Rare Diseases History. We combine innovative biological science with advanced computational algorithms to discover new therapeutic opportunities for rare genetic diseases.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 9/15/2016: Tekuma venture capital transaction
Next: 9/15/2016: Aperia Technologies venture capital transaction
Share this article
Where The Data Comes From
We document every notable VC transaction. VC investment data records reported here are derived from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs